Is reduced-intensity conditioning the standard of care in the transplant setting?
Giralt
Sergio A
SA
Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
D000367:Age Factors; D003657:Decision Making; D006086:Graft vs Host Disease / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D007938:Leukemia / Q000628:therapy*; D019653:Myeloablative Agonists / Q000627:therapeutic use; D019172:Transplantation Conditioning / Q000379:methods*
D019653:Myeloablative Agonists